588 TROPHIMMUN, cohort a: maintained benefit from second-line avelumab after failure to monochemotherapy in low-risk gestational trophoblastic tumor, with a 4 year-follow-up
Benoit You, Adrien Msika, Jean-Pierre Lotz, L. Gladieff, C. Lebreton, T. Hajri, P. Descargues, J. Massardier, Carole Langlois Jacques, Sylvie Bin, Laurent Villeneuve, Adeline Roux, Marine Alves Ferreira, Pascal Rousset, Gilles Freyer, François Golfier, P. Bolze
{"title":"588 TROPHIMMUN, cohort a: maintained benefit from second-line avelumab after failure to monochemotherapy in low-risk gestational trophoblastic tumor, with a 4 year-follow-up","authors":"Benoit You, Adrien Msika, Jean-Pierre Lotz, L. Gladieff, C. Lebreton, T. Hajri, P. Descargues, J. Massardier, Carole Langlois Jacques, Sylvie Bin, Laurent Villeneuve, Adeline Roux, Marine Alves Ferreira, Pascal Rousset, Gilles Freyer, François Golfier, P. Bolze","doi":"10.1136/ijgc-2024-esgo.57","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":517822,"journal":{"name":"Oral Sessions","volume":"89 6","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2024-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Oral Sessions","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1136/ijgc-2024-esgo.57","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
